- Home
- MNPR vs NIM Comparison
MNPR vs NIM Comparison
Compare MNPR & NIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- NIM
- Stock Information
- Founded
- MNPR 2014
- NIM 1992
- Country
- MNPR United States
- NIM United States
- Employees
- MNPR 12
- NIM N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- NIM Trusts Except Educational Religious and Charitable
- Sector
- MNPR Health Care
- NIM Finance
- Exchange
- MNPR Nasdaq
- NIM Nasdaq
- Market Cap
- MNPR 292.9M
- NIM 112.0M
- IPO Year
- MNPR 2019
- NIM N/A
- Fundamental
- Price
- MNPR $48.50
- NIM $9.04
- Analyst Decision
- MNPR Strong Buy
- NIM
- Analyst Count
- MNPR 4
- NIM 0
- Target Price
- MNPR $43.00
- NIM N/A
- AVG Volume (30 Days)
- MNPR 67.7K
- NIM 35.4K
- Earning Date
- MNPR 03-27-2025
- NIM 01-01-0001
- Dividend Yield
- MNPR N/A
- NIM 3.46%
- EPS Growth
- MNPR N/A
- NIM N/A
- EPS
- MNPR N/A
- NIM N/A
- Revenue
- MNPR N/A
- NIM N/A
- Revenue This Year
- MNPR N/A
- NIM N/A
- Revenue Next Year
- MNPR N/A
- NIM N/A
- P/E Ratio
- MNPR N/A
- NIM N/A
- Revenue Growth
- MNPR N/A
- NIM N/A
- 52 Week Low
- MNPR $1.55
- NIM $8.28
- 52 Week High
- MNPR $49.98
- NIM $9.74
- Technical
- Relative Strength Index (RSI)
- MNPR 66.31
- NIM 66.26
- Support Level
- MNPR $34.41
- NIM $8.88
- Resistance Level
- MNPR $44.86
- NIM $9.03
- Average True Range (ATR)
- MNPR 5.69
- NIM 0.10
- MACD
- MNPR 1.13
- NIM 0.02
- Stochastic Oscillator
- MNPR 91.91
- NIM 74.29
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.